Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention.

Flowers CI, O'Donoghue C, Moore D, Goss A, Kim D, Kim JH, Elias SG, Fridland J, Esserman LJ.

Breast Cancer Res Treat. 2013 Jun;139(3):769-77. doi: 10.1007/s10549-013-2576-0. Epub 2013 Jun 14.

2.

Can Radiologists Predict the Presence of Ductal Carcinoma In Situ and Invasive Breast Cancer?

Aminololama-Shakeri S, Flowers CI, McLaren CE, Wisner DJ, de Guzman J, Campbell JE, Bassett LW, Ojeda-Fournier H, Gerlach K, Hargreaves J, Elson SL, Retallack H, Joe BN, Feig SA, Wells CJ; ATHENA Breast Health Initiative.

AJR Am J Roentgenol. 2017 Apr;208(4):933-939. doi: 10.2214/AJR.16.16073. Epub 2017 Feb 15.

PMID:
28199152
3.

Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).

Badan GM, Piato S, Roveda D Júnior, de Faria Castro Fleury E.

Eur J Radiol. 2016 Oct;85(10):1701-1707. doi: 10.1016/j.ejrad.2016.07.010. Epub 2016 Jul 19.

PMID:
27666605
4.

Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.

Ochi M, Kuroiwa T, Sunami S, Murakami J, Miyahara S, Nagaie T, Oya M, Yabuuchi H, Hatakenaka M.

Breast Cancer. 2013 Apr;20(2):137-44. doi: 10.1007/s12282-011-0319-9. Epub 2011 Dec 10.

PMID:
22161277
5.

Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.

Fajardo LL, Pisano ED, Caudry DJ, Gatsonis CA, Berg WA, Connolly J, Schnitt S, Page DL, McNeil BJ; Radiologist Investigators of the Radiologic Diagnostic Oncology Group V.

Acad Radiol. 2004 Mar;11(3):293-308.

PMID:
15035520
6.

[Stereotactic Mammotome breast biopsy: routine clinical experience and correlation with BI-RADS--classification and histopathology].

Michel SC, Löw R, Singer G, Otto R, Hohl M, Kubik RA.

Praxis (Bern 1994). 2007 Sep 26;96(39):1459-74. German.

PMID:
17966279
7.

Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.

Cilotti A, Iacconi C, Marini C, Moretti M, Mazzotta D, Traino C, Naccarato AG, Piagneri V, Giaconi C, Bevilacqua G, Bartolozzi C.

Radiol Med. 2007 Mar;112(2):272-86. Epub 2007 Mar 19. English, Italian.

PMID:
17361370
8.

Automated breast ultrasound: lesion detection and BI-RADS classification--a pilot study.

Wenkel E, Heckmann M, Heinrich M, Schwab SA, Uder M, Schulz-Wendtland R, Bautz WA, Janka R.

Rofo. 2008 Sep;180(9):804-8. doi: 10.1055/s-2008-1027563. Epub 2008 Aug 14.

PMID:
18704878
9.

Comparison of conventional and automated breast volume ultrasound in the description and characterization of solid breast masses based on BI-RADS features.

Kim H, Cha JH, Oh HY, Kim HH, Shin HJ, Chae EY.

Breast Cancer. 2014 Jul;21(4):423-8. doi: 10.1007/s12282-012-0419-1. Epub 2012 Oct 20.

PMID:
23086698
10.

Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?

Arazi-Kleinman T, Causer PA, Jong RA, Hill K, Warner E.

Clin Radiol. 2009 Dec;64(12):1166-74. doi: 10.1016/j.crad.2009.08.003. Epub 2009 Oct 21.

PMID:
19913125
11.

Computer-aided detection in full-field digital mammography: detection in dependence of the BI-RADS categories.

Obenauer S, Sohns C, Werner C, Grabbe E.

Breast J. 2006 Jan-Feb;12(1):16-9.

PMID:
16409582
12.

Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.

Allison KH, Abraham LA, Weaver DL, Tosteson AN, Nelson HD, Onega T, Geller BM, Kerlikowske K, Carney PA, Ichikawa LE, Buist DS, Elmore JG.

Cancer. 2015 May 1;121(9):1369-78. doi: 10.1002/cncr.29199. Epub 2015 Jan 20.

13.

Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition.

Obdeijn IM, Loo CE, Rijnsburger AJ, Wasser MN, Bergers E, Kok T, Klijn JG, Boetes C.

Breast Cancer Res Treat. 2010 Jan;119(2):399-407. doi: 10.1007/s10549-009-0607-7.

PMID:
19876732
14.

Is zero underestimation feasible? Extended Vacuum-Assisted Breast Biopsy in solid lesions - a blind study.

Zografos GC, Zagouri F, Sergentanis TN, Koulocheri D, Nonni A, Oikonomou V, Domeyer P, Kotsani M, Fotiadis C, Bramis J.

World J Surg Oncol. 2007 May 14;5:53.

15.

Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.

Strobel K, Schrading S, Hansen NL, Barabasch A, Kuhl CK.

Radiology. 2015 Feb;274(2):343-51. doi: 10.1148/radiol.14140645. Epub 2014 Sep 29.

PMID:
25271857
16.

Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters.

Mori N, Ota H, Mugikura S, Takasawa C, Tominaga J, Ishida T, Watanabe M, Takase K, Takahashi S.

Eur Radiol. 2013 Oct;23(10):2705-12. doi: 10.1007/s00330-013-2902-2. Epub 2013 Jun 4.

PMID:
23732688
17.
18.

BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ.

Tozaki M.

Breast Cancer. 2013 Jan;20(1):13-20. doi: 10.1007/s12282-011-0312-3. Epub 2011 Nov 23.

PMID:
22109641
19.

The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.

Allen SD, Osin P, Nerurkar A.

Eur J Surg Oncol. 2014 Jul;40(7):824-9. doi: 10.1016/j.ejso.2014.03.022. Epub 2014 Apr 2.

PMID:
24742589
20.

Differentiation of ductal carcinoma in-situ from benign micro-calcifications by dedicated breast computed tomography.

Aminololama-Shakeri S, Abbey CK, Gazi P, Prionas ND, Nosratieh A, Li CS, Boone JM, Lindfors KK.

Eur J Radiol. 2016 Jan;85(1):297-303. doi: 10.1016/j.ejrad.2015.09.020. Epub 2015 Oct 1.

Supplemental Content

Support Center